CrossCoat Medical (CCM) consists of two Strategic Business Units (SBU); Orthopedic and Non-Orthopedic. Each SBU is composed of Treatment Segments (TS). The treatment segments have been identified because they offer:
Adequate size to provide an adequate return on CCM’s efforts
Members of each segment are homogenous while allowing distinction from other segments
Segments are not only identifiable, but reachable in terms of both intermediaries and patients
Segments have competitive products/treatments that require strategic and tactical actions
CCM-D is being designed for applications in the following treatment areas:
Spinal disc treatment with focus on the lower lumbar area.
Application of the agent in areas such as the knee meniscus, Achillies tendon, and shoulder rotator cuff.
Skin application with early emphasis in the area of post-surgical wound dehiscence.
Application of the agent via micro-invasive technique into the soft palate area in the back of the mouth.
Treatment/repair associated with the hand/wrist and foot/ankle.